Market capitalization | €41.80b |
Enterprise Value | €55.06b |
P/E (TTM) P/E ratio | 11.86 |
EV/FCF (TTM) EV/FCF | 6.20 |
EV/Sales (TTM) EV/Sales | 0.71 |
P/S ratio (TTM) P/S ratio | 0.54 |
P/B ratio (TTM) P/B ratio | 1.43 |
Dividend yield | 4.73% |
Last dividend (FY23) | €1.28 |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
21 Analysts have issued a Assicurazioni Generali forecast:
21 Analysts have issued a Assicurazioni Generali forecast:
Jun '24 |
+/-
%
|
||
Revenue | 77,340 77,340 |
3%
3%
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 6,025 6,025 |
10%
10%
|
Net Profit | 3,555 3,555 |
5%
5%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Assicurazioni Generali SpA engages in the provision of insurance and financial products. It operates through the following business segments: Life, Property and Casualty, Asset Management, and Holding and Other Businesses. The Life segment offers coverage through a lump sum or an annuity payment if an event occurs involving human life in exchange for the premium payment as remuneration from the policyholder for the risk taken. The Property and Casualty segment offers insurance against damage to property, personal injury, and public liability. The Asset Management segment provides solutions for the selection and maintenance of listed and unlisted financial instruments in order to generate the best possible return for a given level of risk. The Holding and Other Businesses segment performs parent company functions through the management and coordination of administrative and financial services for the companies in the group. The company was founded on December 26, 1831 and is headquartered in Trieste, Italy.
Head office | Italy |
CEO | Philippe Donnet |
Employees | 81,879 |
Founded | 1831 |
Website | www.generali.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.